We are live on ! Find out more
IRMD icon

iRadimed

139 hedge funds and large institutions have $300M invested in iRadimed in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 33 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,475% more call options, than puts

Call options by funds: $303K | Put options by funds: $4K

100% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 33

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

9% more funds holding

Funds holding: 127139 (+12)

1% more capital invested

Capital invested by funds: $295M → $300M (+$4.35M)

0.84% more ownership

Funds ownership: 53.05%53.89% (+0.84%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
139
Holders Change
+12
Holders Change %
+9.45%
% of All Funds
2.01%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
29
Increased
66
Reduced
33
Closed
16
Calls
$303K
Puts
$4K
Net Calls
+$299K
Net Calls Change
+$52K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.24M +$825K +19,400 +62%
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$2.18M +$29.8K +700 +1%
BAM
28
Ballast Asset Management
Texas
$1.86M +$108K +2,548 +6%
Two Sigma Investments
29
Two Sigma Investments
New York
$1.75M +$370K +8,710 +28%
AAIS
30
ABN AMRO Investment Solutions
$1.33M +$1.29M +30,370 New
CCA
31
Conestoga Capital Advisors
Pennsylvania
$1.21M -$4.25K -100 -0.4%
Janus Henderson Group
32
Janus Henderson Group
United Kingdom
$1.18M +$1.14M +26,905 New
AG
33
Algert Global
California
$1.18M +$520K +12,227 +84%
N
34
Nuveen
North Carolina
$1.17M
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$1.07M +$485K +11,410 +88%
KPP
36
Kings Path Partners
Texas
$1.05M +$1.02M +24,008 New
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
$1.01M +$259K +6,086 +36%
Charles Schwab
38
Charles Schwab
California
$1.01M +$137K +3,224 +16%
Stifel Financial
39
Stifel Financial
Missouri
$978K +$69.8K +1,642 +8%
Squarepoint
40
Squarepoint
New York
$958K +$397K +9,343 +75%
SI
41
Shaker Investments
Ohio
$905K +$14.8K +347 +2%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$846K +$58.7K +1,381 +8%
AC
43
Aristides Capital
Kentucky
$812K
Citadel Advisors
44
Citadel Advisors
Florida
$780K -$596K -14,003 -44%
CAM
45
ClariVest Asset Management
California
$776K +$21K +494 +3%
Allspring Global Investments
46
Allspring Global Investments
North Carolina
$773K +$66.8K +1,570 +10%
JP Morgan Chase
47
JP Morgan Chase
New York
$755K -$598K -14,062 -45%
TI
48
Trexquant Investment
Connecticut
$729K -$84.1K -1,978 -11%
Norges Bank
49
Norges Bank
Norway
$725K +$702K +16,500 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$716K -$17.4K -408 -2%

IRMD Hedge Fund Activity: Q2 2024 in Review

139 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2024, worth a combined $300M — up 1.5% from $295M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IRMD positions and 16 closed out — a net gain of 13 holders — while 66 added to existing stakes and 33 trimmed.

The largest buyer was BlackRock, adding an estimated $6.79M. The largest seller was Soleus Capital Management, cutting an estimated $11M.

  • 139 institutional investors held iRadimed (IRMD) as of Q2 2024, up from 127 in Q1 2024.
  • Funds reported $300M of iRadimed stock for Q2 2024, up 1.5% quarter-over-quarter.
  • 29 funds opened new iRadimed positions in Q2 2024 and 16 closed out, a net change of +13 holders.
  • The largest iRadimed buyer in Q2 2024 was BlackRock, an estimated $6.79M added.
  • The largest iRadimed seller in Q2 2024 was Soleus Capital Management, an estimated $11M sold.

Based on aggregated 13F filings for Q2 2024.